Form 8-K - Current report
SEC Accession No. 0001193125-26-398561
Filing Date
2026-09-23
Accepted
2026-09-23 08:15:05
Documents
13
Period of Report
2026-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d148256d8k.htm   iXBRL 8-K 28080
2 EX-99.1 d148256dex991.htm EX-99.1 7957
6 GRAPHIC g148256g0922122556645.jpg GRAPHIC 6985
  Complete submission text file 0001193125-26-398561.txt   161796

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20260922.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20260922_lab.xml EX-101.LAB 17233
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20260922_pre.xml EX-101.PRE 10810
17 EXTRACTED XBRL INSTANCE DOCUMENT d148256d8k_htm.xml XML 3539
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 261398236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)